Characteristics of patients who were not identified as progressing at the remote review
| Diagnosis | Age (years) | RVA (Snellen) | LVA (Snellen) | RMD (dB) | LMD (dB) | Recommended follow-up remote review (months) |
|---|---|---|---|---|---|---|
| PXF glaucoma | 84 | 6/24 | 6/12 | −1.59 | −0.84 | 12 |
| PXF glaucoma | 74 | 6/6 | 6/6 | −0.74 | −2.79 | 12 |
| PXF glaucoma | 61 | 6/6 | 6/6 | −3.16 | −3.74 | 6 |
| PDG | 66 | 6/6 | 6/9 | −4.11 | −15.81 | 6 |
| POAG | 80 | 6/12 | 6/6 | −22.16 | −12.76 | 6 |
| Suspect | 53 | 6/5 | 6/6 | 0.22 | 0.38 | 12 |
| Suspect | 65 | 6/5 | 6/5 | −1.08 | −3.44 | 6 |
LMD, left visual field mean deviation; LVA, left visual acuity; MD, visual field mean deviation; PDG, pigment dispersion glaucoma; POAG, primary open-angle glaucoma; PXF, pseudoexfoliation; RMD, right visual field mean deviation; RVA, right visual acuity; VA, visual acuity.